12 April 2017
CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION ADR: CLVLY) wishes to advise in accordance with the terms and conditions of issue that the following unquoted conditional performance rights have lapsed and forfeited:
| Class | Number | Exercise price |
| CUVAK Conditional Performance Rights subject to various performance milestones, issued various dates under the 2009 and 2014 Plans | 25,400 | $Nil |
Consequently, there are now 1,882,260 unlisted conditional performance rights on issue.